Axio will be present in thirteen countries including Europe, the Middle-East and Africa
Bengaluru-based start-up, Axio Biosolutions, a medtech company has expanded its operations in the UK. With this launch, Axio will be present in thirteen countries including Europe, the Middle-East and Africa, reinforcing its commitment to address the unmet wound care challenges across the globe. Axio痴 flagship product, Axiostat is an advanced wound management product.
Axiostat is regularly used by Indian Armed forces, BSF, NSG, and other para-military forces, as part of their defense kit, during their operations at the border and conflict zones such as North-East. The Axiostat dressing was famously used in the 2014 Russia-Ukraine conflict, which earned Axio global recognition. This 100 per cent chitosan haemostatic dressing controls severe haemorrhage within minutes through its active adhesion to the trauma wound.
The company’s vision is to become the first choice for any customer looking for advanced, affordable wound care solutions worldwide. To make that happen, Axio has a fully functioning modern Research and Development wing registered in Bengaluru with a GMP, ISO 13485 manufacturing facility situated in Ahmedabad, Gujarat.
EH news bureau
- Advertisement -
Comments are closed.